13 February 2018
Who are we looking for?
Educated to degree level or equivalent in (bio)organic medicinal or computational chemistry or with equivalent experience, you will possess a good understanding of life science organisations and their scientific needs.
Experience in in silico methodologies would be advantageous and some knowledge of toxicity and metabolism would be desirable.
You will also need to be able to demonstrate an aptitude for relationship building and strategic account development as well as being able to travel internationally on a regular basis,
07 February 2018
The opportunity now exists for a highly motivated individual to join our dynamic Sales Team, selling and promoting our software which is used widely in the prediction of the degradation, metabolism and toxicity of chemicals.
12 January 2018
Lhasa Limited has promoted Dr Richard Williams to the position of Chief Scientific Officer (CSO) following a rigorous interview process.
02 January 2018
The Zeneth Knowledge Base 2018.1 is due for release on the 12th January. Keep an eye out for more information.
12 December 2017
This release from Lhasa is comprised of Derek Nexus 6.0, Sarah Nexus 3.0 and Meteor 3.1. Also included are updated knowledge bases for Derek and Meteor Nexus (Derek KB 2018.1, Meteor KB 2018.1).
12 December 2017
Big data is transforming many industries, but the pharmaceutical sector remains steadfast in secrecy. What are the benefits, challenges and considerations surrounding the sharing of proprietary data, and how can an "honest broker" help?
28 November 2017
Lhasa Limited is pleased to announce the upcoming launch of Nexus 2.2 which includes significant software and knowledge updates. This latest release from Lhasa is comprised of Derek Nexus 6.0, Sarah Nexus 3.0 and Meteor 3.1.
22 September 2017
Lhasa Limited has unveiled Setaria, a data management workflow tool created for global healthcare company, GlaxoSmithKline (GSK) PLC.
19 September 2017
Educational charity, Lhasa Limited, has received its second Queen’s Award for Enterprise in a visit from The Vice Lord-Lieutenant of West Yorkshire, Tim Hare.
01 September 2017
40 Million EUR European project for new drug safety assessment and integrative data analysis research.